A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, "Runx1 overexpression ...

Insurance denied 18-year-old Nala White’s surgery for degenerative disc disease. After NBC News reached out, it was approved the next day. By the time she graduated high school, the back pain that ...

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...

In summary, three randomized trials have compared cervical disc replacement to spinal fusion. At two year follow-up, cervical disc replacement appears to be not inferior to fusion for several relevant ...

One of the most common complaints from people is about their sharp and shooting back pain at times, but it is also one of the ...

Tiger Woods has undergone his 7th back surgery following a collapsed disc, a condition where the cushioning disc between ...

Retail chatter around Creative Medical Technology Holdings picked up on Wednesday after the company said the U.S. Food and Drug Administration (FDA) had granted Fast Track status to its lead ...

Although 67% of participants treated with SB-01 achieved the primary endpoint at 6 months, the difference when compared with sham treatment was not statistically significant. Topeline data were ...

Spine BioPharma Announces Topline Results from Phase 3 MODEL Trial For SB-01 (vicatertide) In Chronic Low Back Pain Associated with Degenerative Disc Disease Spine BioPharma, Inc. announced today the ...